INBP
insider transactionsINTEGRATED BIOPHARMA INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·G
Director
$0
2.2M sh
Own -94%
-
Other·G
Director
$0
9.0M sh
Own -79%
-
Other·G
Director
$0
2.2M sh
Own -94%
-
Other·G
Director
$0
9.0M sh
Own -79%
-
Other·G
Director, 10% Owner
$0
2.2M sh
Own -15%
-
Other·G
Director, 10% Owner
$0
9.0M sh
Own -46%
-
Other·G
10% Owner
$0
2.2M sh
Own -100%
-
Other·G
10% Owner
$0
9.0M sh
Own -80%
-
Other·G
Director, 10% Owner
$0
7.4K sh
Own -0%
-
Other·G
Director, 10% Owner
$0
1.4M sh
Own -11%
-
Other·G
Director
$0
7.4K sh
Own -1%
-
Other·G
Director
$0
1.4M sh
Own -50%
-
Other·G
10% Owner
$0
7.4K sh
Own -0%
-
Other·G
10% Owner
$0
1.4M sh
Own -11%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 15, 2026 | William H. Milmoe | Other G | 2.2M | $0 |
| Apr 15, 2026 | William H. Milmoe | Other G | 9.0M | $0 |
| Apr 15, 2026 | William H. Milmoe | Other G | 2.2M | $0 |
| Apr 15, 2026 | William H. Milmoe | Other G | 9.0M | $0 |
| Apr 15, 2026 | Damon Desantis | Other G | 2.2M | $0 |
| Apr 15, 2026 | Damon Desantis | Other G | 9.0M | $0 |
| Apr 15, 2026 | Carl Desantis | Other G | 2.2M | $0 |
| Apr 15, 2026 | Carl Desantis | Other G | 9.0M | $0 |
| Mar 24, 2026 | William H. Milmoe | Other G | 7.4K | $0 |
| Mar 24, 2026 | William H. Milmoe | Other G | 1.4M | $0 |
| Mar 24, 2026 | Damon Desantis | Other G | 7.4K | $0 |
| Mar 24, 2026 | Damon Desantis | Other G | 1.4M | $0 |
| Mar 24, 2026 | Carl Desantis | Other G | 7.4K | $0 |
| Mar 24, 2026 | Carl Desantis | Other G | 1.4M | $0 |
About INBP insider trading
This page tracks insider transactions for INTEGRATED BIOPHARMA INC (INBP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.